• Skip to main content
  • Skip to footer

Juvenescence

Investing in the age of longevity

  • Overview
  • About The Authors
  • Endorsements
  • News
  • About Us
  • SOLD OUT

NEWS

Stem cell transplant ‘game changer’ for MS patients

Results from an international trial show that it was able to stop the disease and improve symptoms.  Read Fergus Walsh’s article on the BBC website. http://www.bbc.co.uk/news/health-43435868

Jim Mellon Speaks to The Business

  Jim Mellon agrees the worst is yet to come for the world’s biggest technology companies, but he thinks bio tech stocks will survive the carnage, as investors look for …

There is no obesity paradox….

The research results here are from the latest in a line of epidemiological studies to firmly refute the obesity paradox, burying it with more data and better study design, to …

Chemotherapy, A Trustee Weapon Against Cancer, Falls Out of Favor by Lucette Lagnado, WSJ

Breast-cancer doctors are at odds over whether some patients should get less chemo—or none at all Doctors are at odds over whether some women with breast cancer should have chemotherapy—one …

Arno Motulsky, a Founder of Medical Genetics, Dies at 94 By DENISE GRADY, New York Times

Dr. Arno G. Motulsky, a former refugee from Nazi Germany who became a founder of medical genetics, recognizing the connection between genes and health long before mainstream medicine did, died …

Live Long and Prosper-Mega In Conversation with Jim Mellon

Genetic engineering, artificial intelligence and cell enhancement therapies will give us the chance to be active, healthy centenarians.  So says Jim Mellon, author of the book Juvenescence.  

« Previous 1 2 3 4 5 Next »

Footer

  • Facebook
  • Twitter

Copyright © 2023 · Privacy Policy